Downregulation of miR‐7116‐5p in microglia by MPP+ sensitizes TNF‐α production to induce dopaminergic neuron damage
Open Access
Abstract
Activation of microglia resulting in exacerbated inflammation expression plays an important role in degeneration of dopaminergic (DA) neurons in the pathogenesis of Parkinson's disease (PD). However, how this enhanced inflammation is induced in microglia remains largely unclear. Here, in the mouse PD model induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetra hydropyridine (MPTP), we found that miR‐7116‐5p in microglia has a crucial role in this inflammation. 1‐methyl‐4‐phenylpyridinium (MPP+) is uptaken by microglia through organic cation transporter 3 (OCT3) to downregulate miR‐7116‐5p, an miRNA found to target tumor necrosis factor alpha (TNF‐α). Production of TNF‐α in microglia is specifically potentiated by MPP+ via downregulation of miR‐7116‐5p to elicit subsequent inflammatory responses. Furthermore, enhancement of miR‐7116‐5p expression in microglia in mice inhibits the production of TNF‐α and the activation of glia, and further prevents loss of DA neurons. Together, our studies suggest that MPP+ suppresses miR‐7116‐5p level in microglia and potentiates TNF‐α production and inflammatory responses to contribute to DA neuron damage.Keywords
Funding Information
- National Natural Science Foundation of China (81130081)
This publication has 51 references indexed in Scilit:
- MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy SubjectsJournal of Molecular Neuroscience, 2014
- Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP+ as Parkinson's disease cellular modelNeuroscience Research, 2013
- The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathwayProceedings of the National Academy of Sciences, 2009
- Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposureGlia, 2004
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's diseaseProgress in Neurobiology, 2001
- Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine TransporterExperimental Neurology, 1999
- Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseNeuroscience Letters, 1994
- Role of Astrocytes in MPTP Metabolism and ToxicityaAnnals of the New York Academy of Sciences, 1992
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985